Results 1 to 10 of about 272,494 (175)

Serological and Histological Evaluation of the Effect of Honeybee Venom on Pancreas and Liver in Diabetic Mice [PDF]

Archives of Razi Institute, 2022
Natural toxins have been traditionally used to trigger several diseases among which bee venom (HBV) is of great importance. The present study aimed to investigate the therapeutic effects of honeybee venom (HBV) on alloxan and glucose fluid-induced Type 2
S. J. J Al-Shaeli, A. M Ethaeb, E. A. N Al-Zaidi   +2 more
doaj   +1 more source

Rhamnetin decreases the expression of HMG-CoA reductase gene and increases LDL receptor in HepG2 cells [PDF]

Journal of Pharmacy & Pharmacognosy Research, 2023
Context: Rhamnetin is a naturally occurring methylated derivative of quercetin. This flavonoid is abundant in Syzygium aromaticum, Coriandrum sativum Prunus cerasus, and Rhamnus spp.
Raghad R. Al-Yousef, Manal M. Abbas, Razan Obeidat, Manal A. Abbas   +3 more
doaj   +1 more source

The Achievement of Non-high-density Lipoprotein Cholesterol Target in Patients with Very High Atherosclerotic Cardiovascular Disease Risk Stratified by Triglyceride Levels Despite Statin-controlled Low-density Lipoprotein Cholesterol

Oman Medical Journal, 2022
Objectives: We sought to estimate the percentage achievements of non-high-density lipoprotein cholesterol (non-HDL-C) target in patients with very high atherosclerotic cardiovascular diseases (ASCVD) risk stratified by triglyceride (TG) levels despite ...
Hilal Al-Sabti, Ali T. Al-Hinai, Ibrahim Al-Zakwani, Khamis Al-Hashmi, Wael Al Mahmeed, Mohamed Arafah, Abdullah Shehab, Omer Al Tamimi, Mahmoud Al Awadhi, Shorook Al Herz, Faisal Al Anazi, Khalid Al Nemer, Othman Metwally, Akram Alkhadra, Mohammed Fakhry, Hossam Elghetany, Abdel Razak Medani, Afzal Hussein Yusufali, Obaid Al Jassim, Omar Al Hallaq, Fahad Omar Ahmed S. Baslaib, Haitham Amin, Khalid Al-Waili, Khalid Al-Rasadi   +23 more
doaj   +1 more source

Association between Low-Density Lipoprotein Cholesterol Level and Cardiovascular Outcomes in Korean Adults: A Nationwide Cohort Study [PDF]

Diabetes & Metabolism Journal, 2023
Background To validate the treatment target of low-density lipoprotein cholesterol (LDL-C) level according to the cardiovascular disease (CVD) risk which was recommended by Korean dyslipidemia guideline.
Junghyun Noh, Min Kyong Moon, Eun-Jung Rhee, Sang Hyun Park, Hyeon Chang Kim, Byung Jin Kim, Hae Jin Kim, Seonghoon Choi, Jin Oh Na, Young Youl Hyun, Bum Joon Kim, Kyung-Do Han, In-Kyung Jeong,   +13 more
doaj   +1 more source

Gender differences in lipid metabolism

Конденсированные среды и межфазные границы, 2021
The search for early markers of atherosclerosis is an effective method for providing personalized medicine allowing the prevention of the progression of this pathology.
Valentina O. Mittova, Anna O. Khoroshikh, Olga V. Zemchenkova, Sergey V. Ryazantsev, Oleg V. Maslov, Elena V. Korzh, Lilia S. Ryasnaya-Lokinskaya, Vladimir V. Alabovsky   +7 more
doaj   +1 more source

HDL and plaque regression in a multiphase model of early atherosclerosis [PDF]

, 2023
Atherosclerotic plaques are accumulations of cholesterol-engorged macrophages in the artery wall. Plaque growth is initiated and sustained by the deposition of low density lipoproteins (LDL) in the artery wall. High density lipoproteins (HDL) counterbalance the effects of LDL by accepting cholesterol from macrophages and removing it from the plaque. In
arxiv   +1 more source

Correlation of fasting lipid profile in non-diabetic CKD patients on conservative management

National Board of Examinations Journal of Medical Sciences, 2023
Background- Chronic kidney disease is emerging as a major chronic disease worldwide. There is surge in incidence of CKD in developing countries that is likely to pose a major problem in both health and economic sector.
Deepak Sha K, Pulkit Jindal, Satarla Narendra   +2 more
doaj   +1 more source

Non-high-density lipoprotein (non-HDL) cholesterol in adolescence as a predictor of atherosclerotic cardiovascular diseases in adulthood [PDF]

Reviews in Cardiovascular Medicine, 2021
Defined as the total cholesterol minus high-density lipoprotein (HDL), non-HDL cholesterol has been increasingly acknowledged as a measure of risk estimation for developing atherosclerotic cardiovascular diseases (ASCVD).
Saeed Shoar, Waleed Ikram, Ahmed Ali Shah, Najam Farooq, Srikanth Gouni, Soheila Khavandi, Elsa Tabibzadeh, Siamak Khavandi   +7 more
doaj   +1 more source

Effect of fenugreek (Trigonella foenum-graecum) seed powder on lipid profile: A single blind placebo controlled study

Journal of Medical and Scientific Research, 2023
Background: Dyslipidemia is one of the most prevalent risk factors contributing to atherosclerotic cardiovascular disease. Clinical trials have demonstrated that treatment of dyslipidemia reduces cardiovascular events.
Amit A, Shubhangi V, Ajay D, Neel C, Kasturi B   +4 more
doaj   +1 more source

Study of pro-oxidant status in acute myocardial infarction

Asian Journal of Medical Sciences, 2018
Background: Apart from several well documented risk factors; oxidative stress may play an important role in the pathogenesis of myocardial infarction. Our study has been designed to investigate the pro-oxidant status in AMI patients who have no previous ...
Tanushri Khatua , Chandan Sarkar , Sujit Kumar Dey, Biswajit Majumder   +3 more
doaj   +1 more source